![PDF) Androgen-AR axis in primary and metastatic prostate cancer: chasing steroidogenic enzymes for therapeutic intervention PDF) Androgen-AR axis in primary and metastatic prostate cancer: chasing steroidogenic enzymes for therapeutic intervention](https://i1.rgstatic.net/publication/360672006_Androgen-AR_axis_in_primary_and_metastatic_prostate_cancer_chasing_steroidogenic_enzymes_for_therapeutic_intervention/links/6284cbc2b2548471fee546a2/largepreview.png)
PDF) Androgen-AR axis in primary and metastatic prostate cancer: chasing steroidogenic enzymes for therapeutic intervention
![Improving CAR-T cell therapy outcomes for patients with for aggressive lymphoma and multiple myeloma | Leukemia and Lymphoma Society Improving CAR-T cell therapy outcomes for patients with for aggressive lymphoma and multiple myeloma | Leukemia and Lymphoma Society](https://www.lls.org/sites/default/files/styles/inspirational_stories_square/public/2022-06/Oliaro-Jane_web_SQ.jpg?itok=NVQz3ZBv)
Improving CAR-T cell therapy outcomes for patients with for aggressive lymphoma and multiple myeloma | Leukemia and Lymphoma Society
![Bioisosteres of Indomethacin as Inhibitors of Aldo-Keto Reductase 1C3 | ACS Medicinal Chemistry Letters Bioisosteres of Indomethacin as Inhibitors of Aldo-Keto Reductase 1C3 | ACS Medicinal Chemistry Letters](https://pubs.acs.org/cms/10.1021/acsmedchemlett.8b00484/asset/images/medium/ml-2018-004844_0001.gif)
Bioisosteres of Indomethacin as Inhibitors of Aldo-Keto Reductase 1C3 | ACS Medicinal Chemistry Letters
Discovery of Novel Aldo-Keto Reductase 1C3 Inhibitors as Chemotherapeutic Potentiators for Cancer Drug Resistance | ACS Medicinal Chemistry Letters
![Development of highly potent and specific AKR1C3 inhibitors to restore the chemosensitivity of drug-resistant breast cancer - ScienceDirect Development of highly potent and specific AKR1C3 inhibitors to restore the chemosensitivity of drug-resistant breast cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0223523422009151-ga1.jpg)
Development of highly potent and specific AKR1C3 inhibitors to restore the chemosensitivity of drug-resistant breast cancer - ScienceDirect
![Development of Potent and Selective Inhibitors of Aldo–Keto Reductase 1C3 (Type 5 17β-Hydroxysteroid Dehydrogenase) Based on N-Phenyl-Aminobenzoates and Their Structure–Activity Relationships | Journal of Medicinal Chemistry Development of Potent and Selective Inhibitors of Aldo–Keto Reductase 1C3 (Type 5 17β-Hydroxysteroid Dehydrogenase) Based on N-Phenyl-Aminobenzoates and Their Structure–Activity Relationships | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/jm201547v/asset/images/large/jm-2011-01547v_0011.jpeg)